RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering

In this podcast, In Vivo speaks to Sara Barrington, CEO of Verici DX. During the discussion, Barrington outlines the current challenges facing patients post-transplant, why current diagnostics are inadequate, and where the overall transplant market is headed, considering the rise of home dialysis and the potential future for xenotransplants.

Episode metadata supplied by the publisher feed · Published Nov 27, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering

0:00 26:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 26 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on November 27, 2023.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!